Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06609174
NA

AI-SCREENDCM Decentralized Clinical Trial - Pilot Study

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the feasibility and impact of screening FDR of DCM probands using a mobile ECG with the ability to transmit the ECG for cloud-based AI analysis to detect reduced left ventricular ejection fraction (LVEF). This protocol will examine the impact of incorporating the screening AI enhanced ECG into standard of care recommendations.

Official title: Artificial Intelligence Electrocardiogram Enabled Mobile Device in Screening Families for Dilated Cardiomyopathy (The AI-SCREENDCM Decentralized Clinical Trial Pilot Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

119

Start Date

2024-10-18

Completion Date

2025-09-26

Last Updated

2026-10-13

Healthy Volunteers

No

Conditions

Interventions

DIAGNOSTIC_TEST

KardiaRx ECG Screening and AI interpretation of ECG

The Kardia 6-lead device is an ambulatory, wireless device that connects to a smartphone. The KardiaRx App processes the signal acquired from the Kardia device into a real-time ECG. ECG will be interpreted by an AI algorithm

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States